“…ln highIy endemic areas such as southern Japan and the West Indies, with a 0.5-5% HTLV-I seroprevaIence among b100d donors Minamoto et al, 1988), multi-transfused patients (Barbara, 1994) including renaI transplant recipients (Linhares et al, 1994) have high HTL V -1 seroprevaIence. Screening of bIood donations has been implemented in Japan (Maeda et al, 1984;Okochi et al, 1984), French Guiana and the Caribbean isIands of Martinique and Guadeloupe (Massari et aL., 1994;PilloneI et aL., 1994), the United States (Williams et al, 1988;Lee et al, 1991;SandIer et al, 1991), Canada, France (Courouc茅 et al, 1993;Massari et al, 1994;PiloneI et al, 1994) and Denmark (Bohn Christian sen et aL., 1995) and Netherlands during the 1ast decade.…”